Stephanie Fichtner1, Heidi L Estner2, Marijana Dzijan-Horn3, Judith Herber3, Konstantinos D Rizas2, Tilko Reents3, Sonia Ammar4, Verena Semmler3, Stefan Kääb2, Gabriele Hessling3, Isabel Deisenhofer3. 1. Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University Munich, Marchioninistr. 15, 81377, Munich, Germany. Stephanie.fichtner@med.uni-muenchen.de. 2. Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University Munich, Marchioninistr. 15, 81377, Munich, Germany. 3. German Heart Center Munich, Department for Electrophysiology, Technische Universitaet Muenchen, Munich, Germany. 4. Department of Cardiology, Hospital Klinikum Coburg, Teaching Hospital of the University of Würzburg, Coburg, Germany.
Abstract
PURPOSE: In some patients, both an electrophysiological examination (EPS) and a coronary angiography (CA) are necessary. It might be preferable to choose a combined approach of EPS and CA versus performing them consecutively. The purpose of this study is to evaluate the type and rate of adverse events between both approaches. METHODS: Patients were eligible if they underwent a CA and an EPS in a combined approach or in a time interval of at most 2 months. In all patients, clinical adverse events were recorded. RESULTS: A total of 1184 patients were included. CA and EPS were performed in a combined procedure (comb) in 492 patients, whereas they were performed consecutively in 692 patients (cons). The acute major complication rate was 0.67%, showing no differences between both groups. In the comb 6.9% and in the cons 6.6% of vascular complications were observed (p = 0.20). The rates of AV fistula and hematoma needing transfusion showed a significantly higher rate in the cons group (p = 0.018 and p = 0.045, respectively). In a multivariate logistic regression analysis, age was a significant predictor for groin complications. After propensity matching, AV fistula occurred significantly more often in the cons group (p = 0.002). CONCLUSION: Overall, serious adverse events were rare and there were no differences between the combined approach of EPS and CA and the consecutive approach; however, the occurrence of AV fistula and groin hematoma needing transfusion occurred significantly less in the combined procedure group. Therefore, a combined approach is preferable to a consecutive one.
PURPOSE: In some patients, both an electrophysiological examination (EPS) and a coronary angiography (CA) are necessary. It might be preferable to choose a combined approach of EPS and CA versus performing them consecutively. The purpose of this study is to evaluate the type and rate of adverse events between both approaches. METHODS:Patients were eligible if they underwent a CA and an EPS in a combined approach or in a time interval of at most 2 months. In all patients, clinical adverse events were recorded. RESULTS: A total of 1184 patients were included. CA and EPS were performed in a combined procedure (comb) in 492 patients, whereas they were performed consecutively in 692 patients (cons). The acute major complication rate was 0.67%, showing no differences between both groups. In the comb 6.9% and in the cons 6.6% of vascular complications were observed (p = 0.20). The rates of AV fistula and hematoma needing transfusion showed a significantly higher rate in the cons group (p = 0.018 and p = 0.045, respectively). In a multivariate logistic regression analysis, age was a significant predictor for groin complications. After propensity matching, AV fistula occurred significantly more often in the cons group (p = 0.002). CONCLUSION: Overall, serious adverse events were rare and there were no differences between the combined approach of EPS and CA and the consecutive approach; however, the occurrence of AV fistula and groin hematoma needing transfusion occurred significantly less in the combined procedure group. Therefore, a combined approach is preferable to a consecutive one.
Authors: Joseph P de Bono; Victoria Mary Stoll; Abishek Joshi; Kim Rajappan; Yaver Bashir; Timothy R Betts Journal: Europace Date: 2010-09-27 Impact factor: 5.214
Authors: Etienne M Aliot; William G Stevenson; Jesus Ma Almendral-Garrote; Frank Bogun; C Hugh Calkins; Etienne Delacretaz; Paolo Della Bella; Gerhard Hindricks; Pierre Jaïs; Mark E Josephson; Josef Kautzner; G Neal Kay; Karl-Heinz Kuck; Bruce B Lerman; Francis Marchlinski; Vivek Reddy; Martin-Jan Schalij; Richard Schilling; Kyoko Soejima; David Wilber Journal: Europace Date: 2009-05-14 Impact factor: 5.214
Authors: A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: S A Chen; C E Chiang; C T Tai; C C Cheng; C W Chiou; S H Lee; K C Ueng; Z C Wen; M S Chang Journal: Am J Cardiol Date: 1996-01-01 Impact factor: 2.778
Authors: Marco Valgimigli; Andrea Gagnor; Paolo Calabró; Enrico Frigoli; Sergio Leonardi; Tiziana Zaro; Paolo Rubartelli; Carlo Briguori; Giuseppe Andò; Alessandra Repetto; Ugo Limbruno; Bernardo Cortese; Paolo Sganzerla; Alessandro Lupi; Mario Galli; Salvatore Colangelo; Salvatore Ierna; Arturo Ausiello; Patrizia Presbitero; Gennaro Sardella; Ferdinando Varbella; Giovanni Esposito; Andrea Santarelli; Simone Tresoldi; Marco Nazzaro; Antonio Zingarelli; Nicoletta de Cesare; Stefano Rigattieri; Paolo Tosi; Cataldo Palmieri; Salvatore Brugaletta; Sunil V Rao; Dik Heg; Martina Rothenbühler; Pascal Vranckx; Peter Jüni Journal: Lancet Date: 2015-03-16 Impact factor: 79.321